|
Committed
to protect Environment,
Health & Safety
An Organization Dedicated to
Prevention of Infectious Diseases and promoting public awareness
and Education about immunization and vaccine-preventable
diseases in Developing Countries
Organization:
JN is a global research-based
company that develops and markets products to protect
from Malaria, TB, HIV and Bacterial meningitis diseases
in more than 30 developing countries since 1998. Now, JN
is a leading innovation-driven Biopharmaceutical
corporation.
JN stands 3rd in the World developed NmVac4-A/C/Y/W135™ (Meningococcal
meningitis groups A, C, Y, W-135) polysaccharide vaccine
for adults & children and stands 2nd in the World
in providing NmVac4-A/C/Y/W135 DT™
(Meningitis A, C, Y, W-135 Diphtheria conjugate)
meningococcal vaccine
for all
ages. JN is a partner of Global Health Organization
such as Clinton Global Initiative, and GBC. JN also
partnering with several other non-profit global
health organizations, NGOs, local governments and
communities in developing countries to address the
health issues related to HIV/AIDS, Malaria, Tuberculosis
and Bacterial Meningitis by underserved communities in
West Africa, South East Asia and Latin Americas.
Global Presence:
The Corporation opened its first overseas branch in 2005
in Abidjan, Côte d'Ivoire and later in 2006 in
Ouagadougou, Burkina Faso. This year (2008) first South
East Asia branch opened in Malaysia. Operating in Africa
and Asia enables the company to more efficiently
distribute many of its products to resource-poor
communities.
Research, Development and Patenting:
JN developing vaccines for prevention and cure for
Hepatitis C, Herpes, Tuberculosis and Stroke, Epilepsy
and Parkinson's disease. While research and development
and clinical trials are in its way, we filed patents to
protect our intellectual properties of our years work
and investment.
|
|
|
With mounting
economic burden exacerbating poverty levels around the
world, health pandemics cutting lives short for millions of
people. JN is committed to provide quality & affordable
healthcare products made in the United States for resource
poor countries.
-
CLINTON GLOBAL INTIATIVE
 |
|
|
VACCINES
Each
year, millions of infants, children and adults die and
suffer from diseases and
disorders that could be prevented by current and future
vaccines.
We are investing to accelerate the development and
introduction of appropriate and affordable vaccines in
impoverished
countries.
Starting with a focus on
vaccines to prevent
Neurological disorders,
Hepatitis C,
Herpes,
Meningococcal meningitis
DIAGNOSTICS
Effective
diagnostics are a crucial element of successful
infectious disease management,
yet their development and use, particularly in the
developing world, remains a neglected area. To address
this deficiency, JN's
HIV
TB
Malaria
pLDH
&
HRP2
produces user-friendly and low-cost and
quality diagnostics for the developing world. Our
point-care rapid diagnostics and ELISA test kits may
facilitate developing countries to efficiently manage
major diseases.
|
NmVac-4
A/C/Y/W-135™
|
